Inspired Nutraceuticals GLX

Inspired Nutraceuticals GLX4 IN 1 COMPLETE GLP 1 System GLX is Inspireds advanced GLP 1 activating metabolic health formula designed to support blood sugar balance, reduce appetite, and restore gut brain metabolism communication. Unlike synthetic GLP 1 receptor agonists, GLX activates the bodys natural pathwayswithout inducing nausea, malabsorption, or dependency. ACTIVATES GLP 1 PATHWAY ACTIVITY Supports natural GLP 1 production to regulate blood sugar and appetite. REBALANCES

4-IN-1 COMPLETE GLP-1 System

GLX is Inspired’s advanced GLP-1-activating metabolic health formula designed to support blood sugar balance, reduce appetite, and restore gut-brain-metabolism communication. Unlike synthetic GLP-1 receptor agonists, GLX activates the body’s natural pathways—without inducing nausea, malabsorption, or dependency.

ACTIVATES GLP-1 PATHWAY ACTIVITY

Supports natural GLP-1 production to regulate blood sugar and appetite.

REBALANCES GUT-METABOLISM CONNECTION

Supports digestive health and metabolic efficiency with targeted probiotics and adaptogens.

SUPPORTS GLUCOSE DISPOSAL & INSULIN SENSITIVITY

Helps your body process carbs more efficiently and maintain stable energy levels.

PROMOTES APPETITE & CRAVING CONTROL

Clinically studied ingredients help reduce hunger and support mindful eating.

A WEIGHT LOSS PRODUCT THAT ACTUALLY ENHANCES GUT HEALTH

GLX contains PRO-GLX™ TriBiomic Complex with three cutting-edge probiotic species:

Bifidobacterium lactis B420
Clinically shown to reduce body fat and improve glucose tolerance. Increases tight junction integrity in the gut and enhances metabolic signaling.

Clostridium butyricum
Butyrate producer; supports GLP-1 expression via SCFA-mediated L-cell activation.

Akkermansia muciniphila
Enhances GLP-1, reduces gut permeability, and improves leptin signaling. Directly tied to metabolic disease prevention.

GLUCOSE DISPOSAL & INSULIN SIGNALING MATRIX

5x more bioavailable than berberine. Increases AMPK activation, improves insulin sensitivity, lowers fasting glucose, and reduces hepatic glucose output.

Chromium potentiates insulin receptor phosphorylation, enhances satiety, and improves glucose handling via PI3K pathway.

Combined, these compounds provide powerful GDA (glucose disposal agent) action while preserving pancreatic beta cell function, something GLP-1 agonists do not address directly.